𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Readministration of tamoxifen after adjuvant therapy for recurrent breast cancer

✍ Scribed by Yukashi Itoh; Hironori Tanaka; Hirotaka Iwase; Shoji Karamatsu; Hiroko Yamashita; Kazuko Itoh; Toshinari Yamashita; Tatsuya Toyama; Yoko Omoto; Shunzo Kobayashi

Publisher
Springer Japan
Year
2000
Tongue
English
Weight
293 KB
Volume
7
Category
Article
ISSN
1340-6868

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Identifying breast cancer patients most
Identifying breast cancer patients most likely to benefit from aromatase inhibitor therapy after adjuvant tamoxifen
✍ Christopher M. Booth; Joseph L. Pater; Paul E. Goss πŸ“‚ Article πŸ“… 2007 πŸ› John Wiley and Sons 🌐 English βš– 38 KB

Identifying Breast Cancer Patients Most Likely to Benefit From Aromatase Inhibitor Therapy After Adjuvant Tamoxifen W e are responding to the recently published study by Freedman and colleagues in which it is suggested that the benefits of adding an aromatase inhibitor after 5 years of adjuvant tamo